Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01793766 · ClinicalTrials.gov registry record · Phase 1
Non-invasive Brain Modulation for Weight Maintenance
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT01793766: Clinical Trial Phase 1 study, sponsored by Massachusetts General Hospital.
NCT01793766 is a Phase 1 study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01793766, a Phase 1 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
This is a study of overweight men and women. Everybody will receive a very low calorie diet to eat in place of meals for 10 weeks. During the last two weeks of the diet, half of the patients will receive an intervention to activate parts of their brain that can help them eat less. The other half of the patient will receive a placebo or sham intervention. The intervention will involve a small electric current given every day for 10 days. Everybody will be monitored for 16 more weeks (total of 26 weeks) while on a weight maintenance diet to see if the intervention helps people keep the weight off.
Interventions
- DEVICE Sham modulation
- DEVICE Brain modulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2013-05 |
| Est. Completion | 2015-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01793766
The ClinicalTrials.gov registry entry for NCT01793766 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham modulation is the first listed.
NCT01793766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01793766 about?
NCT01793766 is a clinical study titled "Non-invasive Brain Modulation for Weight Maintenance". This is a study of overweight men and women. Everybody will receive a very low calorie diet to eat in place of meals for 10 weeks. During the last two weeks of the diet, half of the patients will receive an intervention to activate parts of their brain that can help them eat less. The other half of ...
What is the current status of trial NCT01793766?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2013-05. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01793766?
The interventions under investigation include: Sham modulation (DEVICE), Brain modulation (DEVICE).
Who is sponsoring clinical trial NCT01793766?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.